Jamieson C, Boyd SE, Wootton M, Livermore DM, et al. Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines. J Antimicrob Chemother 2026;81:dkag315.
PMID: 42708708